C12N2760/16023 - CPC Classification Index

#1

20260041756

2026-02-12

INFLUENZA B VIRUS REPLICATION FOR VACCINE DEVELOPMENT

#2

20250122549

2025-04-17

INFLUENZA VIRUS HEMAGGLUTININ MUTANTS

#3

20240390473

2024-11-28

CHIMERIC VIRUS-LIKE PARTICLES AND USES THEREOF AS ANTIGEN-SPECIFIC REDIRECTORS OF IMMUNE RESPONSES

#4

20220242918

2022-08-04

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

#5

20220226460

2022-07-21

Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses

#6

20220202926

2022-06-30

INFLUENZA B VIRUS REPLICATION FOR VACCINE DEVELOPMENT

#7

20210386850

2021-12-16

FUSION PROTEIN

#8

20210371472

2021-12-02

Influenza virus hemagglutinin mutants

#9

20210340184

2021-11-04

INFLUENZA VIRUS HEMAGGLUTINIIN MUTANTS

#10

20210327533

2021-10-21

METHODS FOR GENERATING BROADLY REACTIVE, PAN-EPITOPIC IMMUNOGENS, COMPOSITIONS AND METHODS OF USE THEREOF

#11

20210221854

2021-07-22

SYSTEMS, METHODS, AND CELL LINES FOR GENERATING INFLUENZA VIRUS OR INFLUENZA VIRUS PROTEINS

#12

20210221853

2021-07-22

Influenza virus hemagglutinin mutants

#13

20210207102

2021-07-08

Virus-like particles co-expressing IMC, ROP18, and MIC8, and pharmaceutical composition comprising the same

#14

20210046176

2021-02-18

METHODS OF GENERATING BROADLY PROTECTIVE VACCINE COMPOSITIONS COMPRISING NEURAMINIDASE

#15

20200316190

2020-10-08

Method of inhibiting enveloped virus binding to target cells by incorporating P-selectin glycoprotein ligand-1 (PSGL-1) into virions

#16

20200297836

2020-09-24

Universal virus-like particle (VLP) influenza vaccines

#17

20200223892

2020-07-16

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

#18

20200113996

2020-04-16

Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses

#19

20190314484

2019-10-17

Functional influenza virus like particles (VLPs)

#20

20190091323

2019-03-28

Universal virus-like particle (VLP) influenza vaccines

#21

20190038738

2019-02-07

Functional influenza virus-like particles (VLPS)

#22

20180298063

2018-10-18

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

#23

20180110851

2018-04-26

Functional influenza virus like particles (VLPs)

#24

20170258888

2017-09-14

Influenza B virus replication for vaccine development

#25

20170252427

2017-09-07

Functional influenza virus-like particles (VLPS)

#26

20170232095

2017-08-17

Functional influenza virus-like particles (VLPs)

#27

20160303223

2016-10-20

Universal virus-like particle (VLP) influenza vaccines

#28

20160194662

2016-07-07

RECOMBINANT VIRUS-LIKE PARTICLES ENCODED BY MULTI-GENE VECTOR

#29

20160008456

2016-01-14

Functional influenza virus-like particles (VLPS)

#30

20150374813

2015-12-31

Functional influenza virus like particles (VLPs)

#31

20150306206

2015-10-29

Functional influenza virus-like particles (VLPS)

#32

20150299270

2015-10-22

POLYVALENT INFLUENZA VIRUS-LIKE PARTICLE (VLP) COMPOSITIONS

#33

20130177587

2013-07-11

Functional influenza virus-like particles (VLPs)

#34

20120207786

2012-08-16

Functional influenza virus-like particles (VLPs)

#35

20120064115

2012-03-15

RECOMBINANT VIRUS-LIKE PARTICLES ENCODED BY MULTI-GENE VECTOR

#36

20110212128

2011-09-01

Universal virus-like particle (VLP) influenza vaccines

#37

20100129401

2010-05-27

Functional influenza virus like particles (VLPs)

#38

20090022762

2009-01-22

Polyvalent influenza virus-like particle (VLP) compositions

#39

20080166785

2008-07-10

Polynucleotides allowing the expression and secretion of recombinant HBsAg virus-like particles containing a foreign peptide, their production and use

#40

20070184526

2007-08-09

Functional influenza virus like particles (VLPs)

#41

20060263804

2006-11-23

Functional influenza virus-like particles (VLPs)

#42

20050009008

2005-01-13

Functional influenza virus-like particles (VLPs)